Liver X receptor (LXR) a expression is mainly localized to metabolic tissues, such as the liver, whereas LXRb is ubiquitously expressed. LXRa is activated by oxysterols and plays an important role in the regulation of lipid metabolism in metabolic tissues. In macrophages, LXRs stimulate reverse cholesterol transport and regulate immune responses. Although a high-cholesterol diet induces severe steatohepatitis in LXRa-knockout (KO) mice, the underlying mechanisms linking lipid metabolism and immune responses remain largely unknown. In this study, we investigated the role of LXRa in the pathogenesis of steatohepatitis by assessing the effects of a high-fat and high-cholesterol diet (HFCD) on hepatic immune cell proportion and function as well as lipid metabolism in wild-type (WT) and LXRa-KO mice. HFCD feeding induced severe steatohepatitis in LXRa-KO mice compared with WT mice. These mice had higher cholesterol levels in the plasma and the liver and dysregulated expression of LXR target and proinflammatory genes in both whole liver samples and isolated hepatic mononuclear cells. Flow cytometry showed an increase in CD68 + CD11b + Kupffer cells/ macrophages and a decrease in invariant natural killer T cells in the liver of HFCD-fed LXRa-KO mice. These mice were more susceptible to lipopolysaccharide-induced liver injury and resistant to inflammatory responses against a-galactosylceramide or concanavalin-A treatment. The findings provide evidence for activation of bone marrow-derived Kupffer cells/macrophages and dysfunction of invariant natural killer T cells in LXRa-KO mouse liver. These findings indicate that LXRa regulates hepatic immune function along with lipid metabolism and protects against the pathogenesis of nonalcoholic steatohepatitis.
and have high phagocytic activity and reactive oxygen species production, bone marrow-derived Kupffer cells/ macrophages express F4/80 and CD11b and produce proinflammatory cytokines efficiently (8) . Mice fed a highcholesterol diet or a high-fat and high-cholesterol diet (HFCD) have increased numbers of CD11b + Kupffer cells/macrophages in the liver and are highly susceptible to acute hepatic inflammation induced by cytosinephosphate-guanine oligonucleotide or a-galactosylceramide (a-GalCer) administration (10, 11) . A high-cholesterol diet also induces free cholesterol accumulation in hepatic stellate cells, which are activated by inflammation, and exacerbates hepatic fibrosis induced by bile duct ligation or carbon tetrachloride treatment (12) . Thus, dysregulation of lipid metabolism, specifically cholesterol accumulation, activates hepatic immune cells and induces hepatic inflammatory diseases including NASH. The possible pathophysiological roles of hepatic immune cells, such as the two subsets of Kupffer cells/macrophages, in NAFLD/ NASH induced by dietary cholesterol overload remain largely unknown. The nuclear receptors liver X receptor (LXR) a and LXRb are ligand-dependent transcription factors that are activated by oxysterols and regulate lipid metabolism and immunity (13, 14) . LXRa is mainly expressed in metabolic tissues, such as liver, adipose tissue, and intestine, whereas LXRb is ubiquitously expressed. LXR activation stimulates conversion of cholesterol to bile acids by inducing expression of cholesterol 7a-hydroxylase in the rodent liver and also promotes cholesterol efflux into bile by inducing adenosine triphosphate-binding cassette (ABC) transporter G5 and ABCG8. In macrophages, LXRs stimulate reverse cholesterol transport by inducing expression of ABCA1 and apolipoprotein E (ApoE). A high-cholesterol diet induces more severe hepatic cholesterol accumulation and NASH in LXRa-knockout (KO) mice than in LXRb-KO mice (15, 16) . Hepatic LXRa is necessary for effective biliary and fecal cholesterol excretion and reverse cholesterol transport (17) . Because the liver plays important roles in both lipid metabolism and innate immunity as a gateway for dietary signals, LXRa has been suggested to have a key function as the hepatic cholesterol sensor. In this study, we investigated the role of LXRa in hepatic immune responses in NAFLD mice induced by HFCD and found that LXRa regulates not only hepatic lipid metabolism, but also immune cell function, specifically in CD11b + Kupffer cells/macrophages and NKT cells.
Materials and Methods

Animal studies
Wild-type (WT) C57BL/6J mice were obtained from Nihon CLEA (Tokyo, Japan), and Nr1h3
-/-(Lxra -/-, LXRa-KO) mice were kindly provided by Dr. David J. Mangelsdorf (University of Texas Southwestern Medical Center, Dallas, TX) (15) . Mice were maintained under controlled temperature (23°C 6 1°C) and humidity (45% to 56%) with free access to water and chow. Male mice between 7 and 8 weeks of age were fed a control normal diet (ND) (CE-2; Nihon CLEA) or an HFCD (CE-2 supplemented with 1.25 g/100 g cholesterol and 12.5 g/100 g cocoa butter) as reported previously with minor modification (18) . After the 4-week feeding period, mice were subjected to sample collection or intravenous treatment with Escherichia coli-derived lipopolysaccharide (LPS; Sigma-Aldrich, St. Louis, MO; 2.5 mg/kg of body weight), a-GalCer (Funakoshi Co., Tokyo, Japan; 0.1 mg/kg of body weight), or concanavalin-A (Con-A; Vector Laboratories, Burlingame, CA; 12.5 mg/kg of body weight). Mice were euthanized with carbon dioxide. The experimental protocol adhered to the Nihon University Rules Concerning Animal Care and Use and was approved by the Nihon University Animal Care and Use Committee.
Plasma analysis
Plasma cholesterol, triglyceride, glucose, nonesterified fatty acid (NEFA), aspartate aminotransferase (AST)/alanine aminotransferase (ALT), and total/direct bilirubin levels were measured with Cholesterol E-Test Wako, Triglyceride E-Test Wako, Glucose CII-Test Wako, NEFA C-Test Wako, GOT•GPT CII-Test Wako, and Bilirubin BII-Test Wako (Wako Pure Chemical Industries, Osaka, Japan), respectively. Plasma tumor necrosis factor-a (TNF-a), interferon-g (IFN-g), interleukin12p70 (IL-12p70), chemokine (C-C motif) ligand 2 (CCL2), and IL-4 levels were measured with enzyme-linked immunosorbent assay kits (R&D Systems, Minneapolis, MN).
Liver histology
Liver sections were fixed with 10% neutral buffered formalin (Muto Pure Chemicals, Tokyo, Japan) for 24 hours and embedded with paraffin. The embedded tissues were cut into 5-mm sections, deparaffinized, stained with hematoxylin and eosin (Sakura Finetek Japan, Tokyo, Japan), washed with ethanol and xylene, and mounted with the Histofine Mousestain Kit (Nichirei Corporation, Tokyo, Japan). Oil red O staining was performed on liver frozen sections by Medical & Biological Laboratories Co. (Nagoya, Japan). We used the NASH Clinical Research Network scoring system (19) to assess steatosis, ballooning, and inflammation for a diagnosis of NASH in mice as reported previously (20 
Measurement of lipid contents in liver samples
Liver tissues (0.1 g) were homogenized in cold phosphatebuffered saline on ice. Lipids were extracted with 3 mL of chloroform/methanol (1:2 by volume), next with 3.8 mL of chloroform/methanol (1:2 by volume), and then twice with 3 mL of chloroform. Collected samples were dried up and dissolved in isopropanol. 
Isolation of mouse hepatic MNCs
Hepatic MNCs were isolated with collagenase digestion and Percoll gradient centrifugation as previously described (11) . For detection of NK and NKT cells, hepatic MNCs were isolated without collagenase digestion.
Reverse transcription and quantitative real-time polymerase chain reaction
Complementary DNAs (cDNAs) were synthesized from total RNAs from whole liver or hepatic MNCs using the ImProm-II reverse transcription system (Promega Corporation, Madison, WI), as described previously (21) . Quantitative real-time polymerase chain reaction (PCR) was used with the ABI PRISM 7000 sequence detection system (Thermo Fisher Scientific) using Power SYBR Green PCR Master Mix (Thermo Fisher Scientific). Briefly, after incubation at 95°C for 10 minutes, cDNAs were denatured at 95°C for 15 seconds and annealed and extended with primers at 60°C for 1 minute for each PCR cycle. Intron-spanning primer sequences were as follows: Ccl2, Primer sequences for Nr1h3 (the gene encoding LXRa), Nr1h2 (the gene encoding LXRb), Tnf, Il12b, Ifng, Abca1, Ppib (the gene encoding cyclophilin B), and Gapdh (the gene encoding glyceraldehyde-3-phosphate dehydrogenase) were reported previously (22) (23) (24) (25) . Each primer was used at a final concentration of 0.2 mM. PCR products were quantified with standard curves that were linear over a range of 0.02 to 200 ng/mL for corresponding cDNAs inserted into pcDNA3.1 plasmids (Thermo Fisher Scientific) as reported previously (26) . The calculated RNA values were normalized with the Ppib or Gapdh messenger RNA (mRNA) levels.
Flow cytometric analysis
For analysis of Kupffer cells/macrophages, hepatic MNCs were isolated with collagenase digestion, incubated with anti-CD16/32 Fc blocker (Thermo Fisher Scientific) for 15 minutes at 4°C, and stained with fluorescein isothiocyanate (FITC)-conjugated anti-F4/80 (Thermo Fisher Scientific), biotin-conjugated anti-CD68 (Bio-Rad Laboratories, Hercules, CA), phycoerythrin (PE)-Cy5-conjugated anti-CD11b, and PE-streptavidin (Thermo Fisher Scientific). For analysis of NK cells and NKT cells, hepatic MNCs were isolated without collagenase digestion, incubated with anti-CD16/32 Fc blocker, and stained with FITC-anti-bTCR, PEanti-NK1.1, biotin-anti-CD69, and PE-Cy5-streptavidin (Thermo Fisher Scientific). For analysis of invariant natural killer T (iNKT) cells, hepatic MNCs were isolated without collagenase digestion, incubated with anti-CD16/32 Fc blocker, and stained with FITCanti-NK1.1 (Thermo Fisher Scientific), PE-CD1d-IgG1 dimer (BD Biosciences, San Jose, CA) complexed with a-GalCer, and PE-Cy5-anti-NK1.1 (Thermo Fisher Scientific). Flow cytometric analysis was performed with the Cytomics FC500 
Statistical analysis
Data are presented as means 6 standard deviation. We performed two-tailed unpaired Student t test to assess significant differences between the two groups and one-way analysis of variance (ANOVA) with the Tukey post hoc test or two-way ANOVA for multiple comparisons.
Results
HFCD feeding induces NASH in LXRa-KO mice
Under high-cholesterol diet conditions, LXRa-KO mice exhibit severe cholesterol accumulation in the liver (15, 16) . NAFLD and NASH are associated with lifestyle factors such as a "Western diet" high in fat and cholesterol (1, 27) . We used HFCD as a model for a Western diet and examined the effect of HFCD on lipid metabolism and liver damage in LXRa-KO mice. Peet et al. (15) demonstrate that high-cholesterol diet feeding significantly increases liver mass and plasma AST and ALT levels in LXRa-KO mice within 30 days. Because we also observed that HFCD feeding for 3 to 4 weeks increased liver weight and plasma AST and ALT levels in LXRa-KO mice in preliminary experiments, we compared the effects of 4-week feeding of an HFCD on the development of NAFLD and NASH in LXRa-KO mice vs WT mice.
Similar to high-cholesterol diet feeding (15), HFCD feeding for 4 weeks increased liver weight without changing body weight in LXRa-KO mice, but not in WT mice [ Fig. 1(a) ]. There was no difference in body weight or liver weight between WT and LXRa-KO mice fed an ND. Whereas plasma cholesterol levels were similar in WT and LXRa-KO mice fed an ND, HFCD feeding increased plasma cholesterol levels in LXRa-KO mice more effectively than WT mice [ Fig. 1(b) ]. Plasma triglyceride levels were lower in LXRa-KO mice than in WT mice and were decreased by HFCD feeding compared with ND feeding in both mice [ Fig. 1(b) ]. Plasma glucose and NEFA levels were not altered in all groups [ Fig. 1(b) ]. Plasma AST and ALT levels were strongly elevated in HFCD-fed LXRa-KO mice [ Fig. 1(c) ].
We next evaluated liver histology and hepatic lipid contents. Hematoxylin and eosin staining showed that the liver of HFCD-fed LXRa-KO mice had lipid accumulation, hepatocyte ballooning, and inflammatory cell infiltration [ Fig. 2(a) ]. Oil red O staining showed lipid accumulation in both WT and LXRa-KO mice fed an HFCD, and lipid droplets in LXRa-KO mice were larger than in WT mice [ Fig. 2(a) ]. LXRa-KO had higher scores for steatosis, ballooning, and inflammation compared with WT mice, and a total score in these mice was 7 to 8 [ Fig. 2(b) ], supporting a diagnosis of NASH (19) . Hepatic cholesterol, triglyceride, and NEFA levels were elevated Figure 1 . Body and liver weights and plasma biochemical profiles in WT and LXRa-KO mice fed an ND or HFCD. After WT and LXRa-KO mice were fed an ND or HFCD for 4 weeks, (a) body weight and liver weight per 20 g body weight, (b) plasma cholesterol (CHO), triglyceride (TG), glucose, and NEFA levels, (c) and plasma AST and ALT levels were measured (n = 8 for each group). **P , 0.01; ***P , 0.001 (one-way ANOVA followed by Tukey multiple comparisons).
in HFCD-fed LXRa-KO mice [ Fig. 2(c) ]. Cholesterol levels were also increased in hepatic MNCs [ Fig. 2(d) ]. These findings indicate that HFCD feeding induces NASH in LXRa-KO mice.
HFCD feeding increases expression of genes encoding macrophage activation makers and inflammatory cytokines
LXRa is a transcription factor that induces expression of genes involved in cholesterol metabolism, such as Abcg5 and Abcg8, and represses expression of inflammatory cytokine genes, such as Ccl2 (the gene encoding CCL2, also called monocyte chemotactic protein 1) (28, 29) . We examined expression of immune cell genes to assess whether NASH in LXRa-KO mice is accompanied by increased inflammatory gene expression. In the whole liver of HFCD-fed LXRa-KO mice, expression of Ccl2 and genes of the macrophage activation markers, Adgre1 (the gene encoding F4/80), Itgam (the gene encoding CD11b), and Cd68, was strongly elevated [ Fig. 3(a) ]. HFCD feeding induced expression of the LXR target genes Abcg5 and Abcg8 in an LXRa-dependent manner [ Fig. 3(b) ]. The expression of the gene encoding LXRa (Nr1h3) was not changed by HFCD in WT mice. There was no difference in expression of the gene encoding LXRb (Nr1h2) in WT and LXRa-KO mice fed an ND or HFCD.
Next, we examined gene expression in isolated hepatic MNCs from WT and LXRa-KO mice. Similar to the findings observed in whole liver samples, expression of WT and LXRa-KO mice were fed an ND or HFCD for 4 weeks (n = 3 for each group). **P , 0.01; ***P , 0.001 (one-way ANOVA followed by Tukey multiple comparisons).
Adgre1, Itgam, and Cd68, but not Ccl2, was increased in hepatic MNCs isolated from HFCD-fed LXRa-KO mice [ Fig. 4(a) ]. Expression of Ccl2 in the liver of HFCD-fed LXRa-KO mice is not derived from MNCs, but likely from other cells, such as hepatocytes and hepatic stellate cells. Hepatic MNCs from HFCD-fed LXRa-KO mice showed elevated expression of inflammatory cytokine genes, Tnf, Il12b, and Ifng, and decreased expression of Il4 [ Fig. 4(a) ]. HFCD feeding increased Abcg5 and Abcg8 expression in hepatic MNCs from WT mice, but this effect was not observed in hepatic MNCs from LXRa-KO mice [ Fig. 4(b) ]. Interestingly, HFCD feeding did not change expression of Abca1 or Apoe in hepatic MNCs from WT mice, but increased these mRNA levels in hepatic MNCs from LXRa-KO mice [ Fig. 4(b) ]. Expression of Nr1h3 and Nr1h2 was not changed in hepatic MNCs after HFCD feeding. Thus, deletion of LXRa induces inflammatory gene expression in hepatic MNCs in mice fed an HFCD, consistent with the NASH phenotype observed in LXRa-KO mice. In hepatic MNCs, LXRa is necessary for induction of LXR target genes involved in cholesterol metabolism in a gene-selective manner. We measured plasma levels of TNF-a, IFN-g, IL-12p70, and CCL2 and found that TNF-a, IFN-g, and CCL2 levels were slightly increased in LXRa-KO mice prior to LPS administration when compared with WT mice and Figure 3 . Expression of (a) genes involved in inflammation and (b) LXRs and their target genes in the whole liver of LXRa-KO mice fed an ND or HFCD. WT and LXRa-KO mice were fed an ND or HFCD for 4 weeks, and gene expression analysis was performed in the whole liver samples (ND-fed WT mice, n = 3; HFCD-fed WT mice, n = 4; ND-fed LXRa-KO mice, n = 3; HFCD-fed LXRa-KO mice, n = 4). Adgre1, Itgam, Nr1h3, and Nr1h2 encode F4/80, CD11b, LXRa, and LXRb, respectively. *P , 0.05; **P , 0.01; ***P , 0.001 (one-way ANOVA followed by Tukey multiple comparisons).
that LPS treatment induced higher levels of TNF-a, INF-g, IL-12p70, and CCL2 in LXRa-KO mice than in WT mice [ Fig. 6(b) ]. Plasma AST and ALT levels were also increased after LPS treatment in LXRa-KO mice, whereas these changes were minimal in WT mice [ Fig. 6(c) ].
iNKT cells are decreased and functionally impaired in the liver of HFCD-fed LXRa-KO mice Because NKT cells are present in substantial numbers in the mouse liver (30) Fig. 7(a) ]. CD1d-a-GalCer dimer-positive iNKT cells were also decreased in HFCD-fed LXRa-KO mice, though HFCD feeding did not change the proportion of these cells [ Fig. 7(b) ]. We examined expression of the activation antigen CD69 in NK cells and NKT cells (31) . In the liver of LXRa-KO mice, CD69-positive cells were increased in the NK cell population, but there was no change in the proportion of CD69-positive NKT cells [ Fig. 7(c) ]. Next, we examined whether the diminished number of NKT cells is associated with impaired function of these cells. We administered the iNKT cell-specific activator Figure 4 . Expression of (a) genes involved in inflammation and (b) LXRs and their target genes in hepatic MNCs from LXRa-KO mice fed an ND or HFCD. WT and LXRa-KO mice were fed an ND or HFCD for 4 weeks, and gene expression analysis was performed in isolated hepatic MNCs (ND-fed WT mice, n = 4; HFCD-fed WT mice, n = 5; ND-fed LXRa-KO mice, n = 4; HFCD-fed LXRa-KO mice, n = 5). Adgre1, Itgam, Nr1h3, and Nr1h2 encode F4/80, CD11b, LXRa, and LXRb, respectively. *P , 0.05; **P , 0.01; ***P , 0.001 (one-way ANOVA followed by Tukey multiple comparisons).
a-GalCer to WT and LXRa-KO mice after HFCD feeding for 4 weeks. Before a-GalCer treatment, HFCDfed LXRa-KO mice had slightly higher levels of IFN-g and TNF-a and lower levels of IL-4 compared with HFCD-fed WT mice [ Fig. 8(a) ]. a-GalCer treatment increased plasma levels of IL-4, IFN-g, and TNF-a in WT mice, and this effect was markedly diminished in LXRa-KO mice [ Fig. 8(a) ]. Because NKT cells are involved in Con-A-induced hepatitis (32, 33) , we also examined the activity of NKT cells by evaluating Con-A-induced acute hepatic injury. Necrotic hepatocytes were widely distributed in the liver of HFCD-fed WT mice, but were not observed in LXRa-KO mice [ Fig. 8(b) ]. Con-A treatment increased plasma levels of AST, ALT, total bilirubin, and direct bilirubin in WT mice, but these liver injury markers were increased at lower levels in LXRa-KO mice [ Fig.  8(c) ]. Therefore, hepatic NKT cells are decreased and functionally impaired in the liver of HFCD-fed LXRa-KO mice.
Discussion
In this study, we demonstrate that LXRa regulates not only lipid metabolism, but also immune responses in the liver of mice. HFCD feeding induced apparent NASH in LXRa-KO mice, but only mild hepatic steatosis in WT mice ( Figs. 1 and 2 ). Plasma and liver cholesterol levels were elevated in HFCD-fed WT mice with more profound elevation in HFCD-fed LXRa-KO mice (Fig. 1) . A similar pattern of elevated plasma and liver cholesterol levels was reported in LXRa-KO mice fed a high-cholesterol diet (15) . LXRa-KO mice fed a high-cholesterol diet have decreased triglyceride levels in both plasma and liver (15) . Although plasma triglyceride levels were decreased in 
CD11b
+ Kupffer cells/macrophages are indicated in the right panel (n = 5 for each group). ***P , 0.001 (one-way ANOVA followed by Tukey multiple comparisons).
HFCD-fed LXRa-KO mice, liver triglyceride levels were increased (Fig. 1) . The dietary fat component of the HFCD may affect hepatic triglyceride and fatty liver accumulation in LXRa-KO mice through a lipogenesis-independent mechanism, because LXRa activation induces gene expression involved in lipogenesis (34) . HFCD-fed LXRa-KO mice demonstrated hepatic inflammation (Figs. 2, 4 , and 5), which has been suggested to contribute to the accumulation of triglycerides and fatty acids by decreasing fatty acid oxidation and/or lipoprotein secretion.
Gene expression analysis revealed that HFCD feeding increased expression of Abcg5 and Abcg8 in the liver and hepatic MNCs in WT mice but not LXRa-KO mice (Figs. 3 and 4) , consistent with the previous report (28) . Interestingly, mRNA levels of Abca1 and Apoe in hepatic MNCs were elevated in HFCD-fed LXRa-KO mice compared with HFCD-fed WT mice and ND-fed LXRa-KO mice (Fig. 4) . LXR ligand treatment increases expression of these genes in macrophages in a manner dependent on both LXRa and LXRb (35, 36) . Synthetic LXR ligand treatment can induce Abca1 expression and stimulate cholesterol efflux in macrophages from LXRa-KO mice (37, 38) . HFCD feeding did not change expression of Nr1h2 (the gene encoding LXRb) in hepatic MNCs from WT mice or LXRa-KO mice (Fig. 4) , but increased cholesterol levels in hepatic MNCs from LXRa-KO mice (Fig. 2) . These findings suggest that LXRb is activated and induces expression of Abca1 and Apoe in HFCD-fed LXRa-KO mice, but that activity is insufficient to compensate for the loss of LXRa. We cannot exclude the possibility of an LXR-independent mechanism of regulation of Apoe and Abca1 expression. Further studies using hepatic MNCs from LXRb-KO mice and/or LXRa/b double KO mice are needed to elucidate the role of LXRb in NASH pathogenesis.
Expression of Adgre1, Itgam, and Cd68, which encode F4/80, CD11b, and CD68, respectively, was increased in both whole liver and hepatic MNCs of HFCDfed LXRa-KO mice (Figs. 3 and 4) . In agreement with the gene expression results, flow cytometry revealed an increase of the F4/80
+ cell population (Fig. 5 ). By contrast, Ccl2 mRNA levels were elevated in whole liver but not in hepatic MNCs in HFCD-fed LXRa-KO mice (Figs. 3 and 4) . Ccl2 expression is induced in hepatocytes, hepatic stellate cells, and sinusoidal endothelial cells after inflammatory stimulation (39) (40) (41) , and LXRa regulates metabolism and immunity in these cells (42-44). Arrowheads indicate infiltration of MNCs in periportal areas. Scale bar, 100 mm. Plasma samples were collected at 0, 1, 3, and 6 hours after LPS injection and subjected to measurement of (b) proinflammatory cytokines and (c) aminotransferases (n = 8 for each group). Insets show magnified views of the indicated data points. There were significant differences between WT mice and LXRa-KO mice for all panels of (b) and (c) (P , 0.001; two-way ANOVA). *P , 0.05; **P , 0.01; ***P , 0.001 compared with WT mice at the same time point (two-tailed unpaired Student t test). HFCD-fed LXRa-KO mice had increased proinflammatory cytokines in the plasma (Fig. 6 ), in agreement with the role of CD68 +
+ Kupffer cells/macrophages in cytokine production after LPS stimulation (8) . This type of Kupffer cell/macrophage also accumulates in the liver of fibroblast growth factor 5-deficient mice fed a high-fat diet, a model of severe NASH (20) . Because LXRa is involved in Conversely, iNKT cells were significantly decreased in the liver of HFCD-fed LXRa-KO mice (Fig. 7) . The function of iNKT cells in LXRa-KO mice in producing IL-4 and IFN-g after a-GalCer stimulation was also suppressed, and Con-A-induced liver injury was attenuated in LXRa-KO mice (Fig. 8) . These findings identify decreased number and function of iNKT cells in the liver of LXRa-KO mice. Kupffer cell activation results in decreased hepatic NKT cell number in mice with hepatic steatosis (46, 47) . A decrease of NKT cells was also observed in human livers with severe steatosis (46) . Thus, decreased iNKT cells in the liver of LXRa-KO mice may be a consequence of Kupffer cell activation. On the other hand, NKT cell activation enhances the pathogenesis of atherosclerosis and hepatic steatosis with increased proinflammatory cytokine levels (48) (49) (50) Con-A-induced hepatitis is mediated by NKT cells (32, 33) . LXRa-KO mice were resistant to Con-A-induced liver injury compared with WT mice, although they had more lipid accumulation with HFCD feeding (Fig. 8) . Recently, it was reported that NKT cells play a role in the healing response after liver injury by regulating the inflammatory reaction (51) . Decreased iNKT function may enhance liver damage in HFCD-fed LXRa-KO mice. Although Con-A is widely used in a murine model of autoimmune hepatitis, Con-A is not a causative agent of human hepatitis and the role of NKT cells in human autoimmune hepatitis remains elusive (52) . Further studies are needed to elucidate potential roles of LXRa in hepatic iNKT cell function and pathogenesis of autoimmune hepatitis.
In conclusion, LXRa controls hepatic immune cell populations and function along with lipid metabolism. LXRa is suggested to play a role in the gateway function of the liver as a lipid sensor and regulator of metabolism and immunity.
